|KDEV -- Sweden Stock|| |
SEK 9.18 0.26 2.91%
Dr. Jim Van Heusden, Ph.D. has served as Chief Executive Officer of Karolinska Development AB since March 3, 2015. Jim Van Heusden has over 20 years of experience within VC, research and development within the pharmaceutical industry, including as Founder and Managing Director at bioskills and as Partner at the European investment company Gimv . During his appointment at Gimv he also served as a Board member in several biotech companies including Multiplicom NV, Ablynx NV, ActoGeniX NV, Pronota NV and Prosensa. During 19932001, Jim Van Heusden worked as Senior Scientist at Janssen Pharmaceuticals . He has a Ph.D. in molecular and cellular biology from the University of Maastricht.
Age: 44 CEO Since 2015 Ph.D
46 8 52 48 60 70 http://www.karolinskadevelopment.com